['anemia', 'dialysis dependent chronic kidney disease']
['vadadustat', 'placebo']

        Inclusion Criteria:

          -  Male and female Japanese subjects ≥20 years of age

          -  Receiving chronic maintenance hemodialysis for end-stage kidney disease

          -  Hb <10.0 g/dL

        Exclusion Criteria:

          -  Anemia due to a cause other than CKD or presence of active bleeding or recent blood
             loss

          -  Sickle cell disease, myelodysplastic syndromes, bone marrow fibrosis, hematologic
             malignancy, myeloma, hemolytic anemia, thalassemia, or pure red cell aplasia

          -  Red blood cell transfusion within 4 weeks prior to or during screening

          -  Anticipated to recover adequate kidney function to no longer require hemodialysis
             during study participation
      